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Abstract

Living systems protect themselves from aberrant proteins by a network of chaperones. We have tested in vitro
the effects of different concentrations, ranging from 0 to 16 μm, of two molecular chaperones, namely αBcrystallin and clusterin, and an engineered monomeric variant of transthyretin (M-TTR), on the morphology
and cytotoxicity of preformed toxic oligomers of HypF-N, which represent a useful model of misfolded
protein aggregates. Using atomic force microscopy imaging and static light scattering analysis, all were found
to bind HypF-N oligomers and increase the size of the aggregates, to an extent that correlates with chaperone
concentration. SDS-PAGE profiles have shown that the large aggregates were predominantly composed of the
HypF-N protein. ANS fluorescence measurements show that the chaperone-induced clustering of HypF-N
oligomers does not change the overall solvent exposure of hydrophobic residues on the surface of the
oligomers. αB-crystallin, clusterin and M-TTR can diminish the cytotoxic effects of the HypF-N oligomers at
all chaperone concentration, as demonstrated by MTT reduction and Ca2+ influx measurements. The
observation that the protective effect is primarily at all concentrations of chaperones, both when the increase
in HypF-N aggregate size is minimal and large, emphasizes the efficiency and versatility of these protein
molecules.
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Abstract
Living systems protect themselves from aberrant proteins by a network of chaperones. We have
tested in vitro the effects of different concentrations, ranging from 0 to 16 µM, of two molecular
chaperones, namely B-crystallin and clusterin, and an engineered monomeric variant of
transthyretin (M-TTR), on the morphology and cytotoxicity of preformed toxic oligomers of HypFN, which represent a useful model of misfolded protein aggregates. Using atomic force microscopy
imaging and static light scattering analysis, all were found to bind HypF-N oligomers and increase
the size of the aggregates, to an extent that correlates with chaperone concentration. SDS-PAGE
profiles have shown that the large aggregates were predominantly composed of the HypF-N protein.
ANS fluorescence measurements show that the chaperone-induced clustering of HypF-N oligomers
does not change the overall solvent exposure of hydrophobic residues on the surface of the
oligomers. B-crystallin, clusterin and M-TTR can diminish the cytotoxic effects of the HypF-N
oligomers at all chaperone concentration, as demonstrated by MTT reduction and Ca2+ influx
measurements. The observation that the protective effect is primarily at all concentrations of
chaperones, both when the increase in HypF-N aggregate size is minimal and large, emphasises the
efficiency and versatility of these protein molecules.
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Introduction
A large number of pathological conditions arise from the failure of polypeptide chains to adopt or to
remain in their native conformational states (Chiti and Dobson, 2006). These conditions are
generally described as protein misfolding, or protein conformational, diseases and may result in loss
of function or a gain of toxic function. Most of these diseases are associated with the conversion of
specific proteins from their soluble states into aggregated species that thus become deposited within
organs and tissues, either as intracellular inclusions or their deposition as extracellular deposits
(Chiti and Dobson, 2006; Rambaran and Serpell, 2008). Molecules with chaperone activity are key
components of the quality control processes used by living systems to maintain protein homeostasis
in the highly crowded cellular environment. The majority of chaperones are located within cells
Hartl et al., 2011; Bukau et al., 2006), but the presence of protective guardians in the extracellular
environment collectively referred to as extracellular chaperones is now widely acknowledged
(Wyatt et al. 2012; Wyatt et al., 2013). Typically, chaperones prevent the aggregation of unfolded
polypeptide chains (“holdase” activity) and/or promote their de novo protein folding or refolding,
i.e. “foldase” activity (Hartl et al., 2011; Kim et al., 2013). Some molecular chaperones can also
disaggregate protein aggregates (Weibezahn et al., 2005; Winkler et al., 2012; Hodson et al., 2012)
or cooperate with proteases to facilitate protein degradation (Pickart and Cohen, 2004; Alexopoulos
et al., 2012; Li and Lucius, 2013).
In addition to these functions, chaperones have recently been found to suppress in vitro the
toxic effects of protein aggregates after the aggregates have formed (Ojha et al., 2011; Mannini et
al., 2012; Cascella et al., 2013a; Cascella et al., 2013b; Binger et al., 2013). In particular, it has been
found for a range of systems that misfolded protein oligomers, incubated with sub-stoichiometric
concentrations of chaperones in vitro, can be converted into large aggregates with substantially
reduced toxicity, in the absence of any significant structural reorganisation of the individual
molecules within the aggregates (Mannini et al., 2012). It was also found that fibrils formed by
apolipoprotein C-II were converted into large fibrillar tangles in the presence of a small heat shock
protein (Binger et al., 2013). In a recent report it was found that long-lived daf-2 mutant C. elegans
strains were characterised by the accumulation of large chaperone-containing aggregates during
aging, relative to age-matched wild-type controls that had a normal lifespan (Walther et al. 2015).
This chaperone-driven aggregation process was suggested to neutralise potentially harmful, soluble,
oligomeric proteins into innocuous large aggregates. It was found to maintain the proteome in the
mutant nematodes, therefore representing an important part of their protein homeostasis system and
ability to extend their lifespan (Walther et al. 2015). Hence, it appears that the ability of chaperones
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to neutralize preformed toxic aggregates is an important feature of the behaviour of these molecules,
and in the present paper we describe further studies of this phenomenon over a wide range of
concentrations both above and below stoichiometric ratios of chaperones to oligomers.
We have tested the effects of different concentrations of two recognised molecular
chaperones, namely B-crystallin (Bc), as an example of an intracellular chaperone, and clusterin
(Clu), as an example of an extracellular chaperone, on the toxicity of oligomers formed from the Nterminal domain of HypF protein from Escherichia coli (HypF-N). We have also tested on the same
aberrant protein oligomers the effect of various concentrations of an engineered monomeric variant
of transthyretin (M-TTR) containing two mutations (Phe87Met and Leu110Met) that prevent it
from forming normal tetramers (Jiang et al., 2001). Although M-TTR and tetrameric TTR are not
generally classified as chaperones, they have been found to act in a chaperone-like manner on a
subset of amyloidogenic client proteins: they effectively inhibit the aggregation of the amyloid 
peptide (A) associated with Alzheimer’s disease and suppress the toxicity of these aggregates and
other oligomeric proteins (Li et al., 2011; Cascella et al., 2013a; Li et al., 2013; Buxbaum et al.,
unpublished). Further, in neurons (but not in liver) TTR has been shown to be regulated by the
stress responsive heat shock factor 1 (HSF-1) in parallel with the classical heat shock proteins
Hsp40, Hsp70 and Hsp90 (Wang et al., 2014).
We decided to assess the effect of these three proteins on HypF-N oligomers because HypFN is an amyloidogenic protein and a good model system for a number of reasons. First, it forms
fibrils that are morphologically, tinctorially and structurally similar to those found in amyloid
deposition diseases (Chiti et al., 2001; Relini et al., 2004). Second, HypF-N forms pre-fibrillar
oligomers that are toxic to cells in culture and in animal models (Bucciantini et al., 2002;
Bucciantini et al., 2004; Cecchi et al., 2005; Baglioni et al., 2006; Pellistri et al., 2008). Furthermore,
HypF-N pre-fibrillar oligomers have similar pathogenic effects as A oligomers on cells at the
biochemical, molecular, electrophysiological and animal level (Bucciantini et al. 2004; Tatini et al.,
2013). Moreover, under two different solution conditions (conditions A and B, respectively), HypFN very reproducibly forms two well-characterised types of oligomers with similar morphology but
different toxicities (Campioni et al., 2010; Zampagni et al., 2011; Evangelisti et al., 2012; Tatini et
al., 2013; Mannini et al., 2014).
In this study we have found that Bc, Clu and M-TTR can promote clustering of the HypFN type A oligomers into larger species, with sizes that in each case increase linearly with chaperone
concentration. We have also observed that concentrations of each of the three chaperones below as
well as above stoichiometric ratios relative to HypF-N are sufficient to suppress the toxicity of
HypF-N oligomers. Indeed, inhibition of HypF-N oligomer toxicity is also achieved even under
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conditions when there is minimal increase in oligomer size, demonstrating the efficacy of these
species to suppress oligomer toxicity by a variety of mechanisms.

Results
HypF-N oligomers are insoluble over a wide range of protein concentration. The formation of
HypF-N oligomers was verified by SDS-PAGE: samples containing oligomeric and native HypF-N
at 4 µM concentration (equivalent monomer concentration) were centrifuged in order to separate
pellet (P) and supernatant (SN) fractions and these were loaded onto a gel. In the sample containing
native HypF-N, the HypF-N band (MW 10.5 kDa) was observed only in the SN fraction, whereas
in the sample containing HypF-N oligomers the HypF-N band was found only in the P fraction (Fig.
1A). The larger intensity of the latter band arises from the higher amount of protein loaded onto the
electrophoretic gel.
In our prior studies of HypF-N oligomers and chaperones, we used preformed HypF-N
oligomers at an equivalent monomer concentration of 12 µM (Mannini et al., 2012; Cascella et al.,
2013a), a concentration that is too high for the purpose of studying the effect of a wide range of
chaperone concentrations, ranging from sub- to super-stoichiometric, on the morphology and
cytotoxicity of HypF-N oligomers. In particular, super-stoichiometric concentrations (i.e. >>12
µM) are too high, due to the difficulties associated with the poor solubility of some chaperones at
these concentrations (see below). To choose the range of concentration of HypF-N oligomers
optimal for the current investigation, the oligomers were diluted into 20 mM potassium phosphate,
pH 7.0, to final concentrations ranging from 0 to 14 M (monomer concentration) and analysed
using static light scattering (SLS). A linear relationship was found between the concentration of
HypF-N oligomers and the intensity of scattered light, suggesting that lower protein concentrations
do not induce dissociation of the oligomers and the light scattering intensity is linearly proportional
to the concentration of aggregated particles in suspension (Fig. 1B). A concentration of 4 M was
therefore chosen as a good compromise to evaluate the effect of both sub-stoichiometric and superstoichiometric chaperone concentrations on the size and toxicity of HypF-N oligomers.
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Figure 1: Preliminary analysis of HypF-N oligomers. (A) SDS-PAGE analysis of the pellet (P) and
supernatant (SN) fractions obtained from samples containing native HypF-N or HypF-N oligomers through
centrifugation. (B) Static light scattering intensity expressed as kilocounts per second (kcps) of HypF-N
oligomers at different concentrations. The data can be fit with a straight line, described by the equation in the
figure.

The size of HypF-N oligomers increases with Bc, Clu and M-TTR concentration. To
investigate the effects of different concentrations of Bc, Clu and M-TTR on HypF-N aggregate
size, we incubated the oligomers (at a concentration equivalent to 4 M monomer) in the presence
of increasing concentrations of each chaperone (0-16 µM) and measured the intensity of scattered
light (Fig. 2A-C). Relative to the sample containing oligomers alone, the intensity of scattered light
was found to increase with the concentration of each chaperone. The increase in light scattering
intensity was less marked at low concentrations of each chaperone, but became highly significant at
high concentrations.
The soluble chaperones provide a small but significant contribution to light scattering. To
exclude the possibility that the observed increase in light scattering intensity coinciding with
increases in chaperone concentration solely arose from the chaperones themselves, we performed
6

control experiments using 16 M Bc, Clu or M-TTR alone, which corresponds to the highest
chaperone concentration used in all our experiments. The low values of light scattering intensity
observed with 16 µM Bc, Clu and M-TTR alone suggest that the soluble chaperones cannot
account for the increase in light scattering intensity observed in the samples containing both
oligomers and chaperones (Fig. 2).
We also used AFM imaging to determine the morphology and size of HypF-N oligomers in the
presence of increasing concentrations of Bc, Clu or M-TTR (Fig. 3A-C). In the absence of
chaperones the oligomers appear as small spheroids with a height of 2.8 ± 0.2 nm (n = 101). This
value results from the cross sectional measurements corrected by a shrinking factor of 1.7 and is
consistent with that previously reported for HypF-N oligomers (Campioni et al., 2010). In the
presence of Bc, Clu and M-TTR at low concentration, we observed aggregates with similar or
only slightly higher size. In the presence of the same three proteins at higher concentration, we
observed discrete larger aggregates. The largest aggregates were found in samples containing the
highest concentration of the chaperones. A quantitative analysis of the sizes of various HypF-N
aggregates in the presence of each chaperone showed that both height and width values increase
with Bc, Clu and M-TTR concentration (Fig. 3D). We did not correct the heights of the aggregates
obtained in the presence of chaperones by the shrinking factor in this analysis, as this factor was
determined for oligomers alone. Therefore, the aggregate heights reported in Fig. 3D should be
compared with the uncorrected HypF-N oligomer height, which is 1.66 ± 0.09 nm (n = 101). As a
control experiment, large aggregates were not observed in samples containing 2.4 M Bc alone, as
reported previously (Mannini et al., 2012).
In conclusion, since the concentration of HypF-N is 4 M in all cases, the measured increase in
aggregate size following the addition of chaperones indicates that the HypF-N oligomers either
assemble into larger aggregates in the presence of chaperones or recruit the chaperones themselves
into the aggregates.
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Figure 2: Static light scattering intensity measurements (kcps) of HypF-N oligomers (4M monomer
concentration) incubated with the indi- cated concentrations of Bc (A), Clu (B) and M-TTR (C). Samples
containing 16 M Bc, Clu or M-TTR are also reported. Error bars correspond to standard errors (SEM) of
the means of 4 measurements. The single, double and triple asterisks indicate a significant difference (p0.05,
p0.01, p0.001, respectively) relative to the sample containing the oligomers alone.
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Figure 3: AFM analysis of HypF-N oligomers. (A–C) TM-AFM images (left, height data; right, amplitude
data) of HypF-N oligomers (equivalent to 4 M monomer concentration) pre-incubated with Bc (A), Clu
(B), M-TTR (C) at the indicated chaperone concentrations. The scan size is 1.0 m. The Z range is (with
increasing chaperone concentration) 10 nm, 27 nm, 20 nm, 30 nm, 40 nm, 40 nm(A); 6 nm, 40 nm, 8 nm, 18
nm, 10 nm, 35 nm (B);12 nm, 8 nm, 15 nm, 20 nm, 120 nm, 12 nm (C). (D) The size of HypF-N
aggregates in the presence of Bc (top), Clu (middle) or M-TTR (bottom) is measured from the topographic TM-AFM images as the maximum and minimum widths (right panels, red and black circles,
respectively) and as the heights evaluated along the sections corresponding to the maximum and minimum
widths (left panels, red and black circles, respectively).
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The large aggregates primarily contain HypF-N. To determine whether the large aggregates
formed in the presence of 4 µM HypF-N and 16 M Bc, Clu and M-TTR were constituted
predominantly of HypF-N, or were complexes of HypF-N and chaperone, we analysed the samples
using SDS-PAGE (Fig. 4). In the samples containing HypF-N oligomers alone the HypF-N band
(MW 10.5 kDa) was present only in the P fraction (Fig. 4). In the three samples containing only 16
M Bc, Clu or M-TTR, the Bc band (MW  20 kDa), the Clu band (MW 36 kDa) and the MTTR band (MW 14 kDa) were found mainly in the SN fraction, although unexpectedly a weak
band was also present in the P fraction, suggesting that a very small, yet significant, percentage of
each of these proteins were in an aggregated state at these concentrations (Fig. 4).
In the samples containing both HypF-N oligomers (4 µM monomer) and 16 M chaperone the
HypF-N band was visible only in the P fraction, whereas the bands representing Bc, Clu and MTTR were visible in both the P and SN fractions, with the large majority of protein present in the
SN fraction (Fig. 4). For each of the three chaperones, the band intensity in the P sample containing
oligomers and chaperone, determined using densitometry analysis, was weak and only slightly
higher than that determined in the P sample containing chaperone alone. This result suggests that
the large species observed when HypF-N oligomers were incubated at the highest chaperone
concentration did not arise from the recruitment of all available chaperone to the HypF-N oligomers,
but rather from the further assembly of pre-existing HypF-N oligomers induced by a small fraction
of chaperone that remains associated with these assemblies.
Overall, the SDS-PAGE results show that (i) each chaperone is significantly insoluble at the
concentration of 16 µM, (ii) each chaperone binds HypF-N oligomers only marginally, as the small
fraction present in the pellet when both chaperone and oligomers are present results in part from the
intrinsic insolubility of a small fraction of the chaperone at this concentration, (iii) the large
aggregates observed in the presence of both HypF-N oligomers and chaperone result from the
chaperone-induced assembly of HypF-N oligomers into larger species, which appear to consist
predominantly of the HypF-N protein.
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Figure 4: SDS-PAGE on samples containing HypF-N oligomers and Bc (A), Clu (B) and M-TTR (C).
The samples were prepared by incubating HypF-N oligomers (4 M monomer) and each chaper- one (16
M) separately or together. They were then centrifuged for 10 min at 16 100 g and the P and SN fractions
were collected and analyzed by reducing SDS-PAGE. The bands at 10, 20, 36 and 14 kDa correspond
to HypF-N (A–C), Bc (A), Clu (B) and M-TTR (C), respectively. In (B) a lower amount of unprocessed
(single chain) and variably glycosylated Clu are also visible at higher molecular weights (black arrow).

Bc, Clu and M-TTR partially aggregate at moderately high concentration. As further
evidence that Bc, Clu and M-TTR aggregate at 16 µM concentration, we assessed the size
distributions of Bc, Clu and M-TTR alone by light scattering (Fig. 5). The peak at 18.80.4 nm
observed in the presence of 16 M Bc (Fig. 5A) is consistent with the hydrodynamic diameter of
native Bc (13.5 nm), as reported previously (Haley et al., 1998; Burgio et al., 2001; Peschek et
11

al., 2009). Indeed, Bc is an oligomer in its native state (Aquilina et al., 2003). In the sample
containing Clu, the weak peak at 11.50.8 nm (Fig. 5B) is consistent with the hydrodynamic
diameter of native Clu, as reported previously (Wyatt et al., 2009). This peak is partially masked by
species of larger diameter, notably in the ranges of 30-80 nm and 100-600 nm, indicating the
presence of a variety of aggregates in solution. Since the intensity of light scattering scales with the
square of the particle mass, the predominance of these peaks in the DLS intensity distribution does
not indicate that most of Clu is aggregated. Rather, the DLS intensity distribution indicates that
most of the Clu adopts a native structure. However, it also provides evidence that aggregates are
present. Aggregates were also found in the samples containing M-TTR (Fig. 5C), where they
completely mask the peak related to the soluble form of M-TTR found at 4.50.6 nm (Conti et al.,
2014; Pires et al., 2012; Jiang et al., 2001).
The presence of protein aggregates in samples containing 16 µM chaperone was unexpected. We
therefore repeated the experiments with Clu at this concentration, but in this case centrifuging and
filtering (0.02 µM cutoff) the sample before measuring the DLS distributions at various time points.
The aggregates appeared to be present from the start of the experiment, suggesting that they form
and equilibrate very rapidly after centrifugation/filtration (data not shown). Since all three
chaperones were lyophilised after purification and resuspended immediately before the experiments,
these aggregates likely originate from the lyophilisation and resuspension procedure. We therefore
analysed by DLS a sample of Clu purified from human plasma that had not undergone
lyophilisation. The DLS distribution indicates that monomeric species are dominant, with only a
very small number of aggregates of diameter 30-80 nm and no aggregates with a size larger than
100 nm (Fig. 5D).
Overall, the DLS results confirm the data obtained by the SDS-PAGE analysis and suggest that
lyophilised/reconstituted Bc, Clu and M-TTR partially assemble into aggregates at the highest
concentration studied here. Purified chaperones that have not been subjected to lyophilisation and
reconstitution do not, however, form significant amounts of these aggregates. Similar behaviour has
been observed for -synuclein (Chen et al. 2015).
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Figure 5: DLS analysis of chaperones. Size distributions by light scattering intensity of Bc (A), Clu (B),
M-TTR (C) and Clu before lyophilization (D) at a concentration of 16 M acquired after incubation of each
chaperones for 1 h at 37 °C with shaking in 20 mm potassium phosphate pH 7.0.

Solvent-exposed hydrophobicity of HypF-N oligomers in presence of Bc, Clu and M-TTR. A
number of studies indicate that an increase in the exposure of hydrophobic groups on the surface of
oligomers positively correlates with their ability to cause cellular dysfunction (Oma et al., 2005;
Bolognesi et al., 2010; Olzscha et al., 2011; Ladiwala et al., 2012). This has also been observed for
HypF-N oligomers (Campioni et al., 2010; Bemporad and Chiti, 2012). To investigate changes in
the extent of exposed hydrophobicity on HypF-N oligomers following the addition of chaperones,
we measured the fluorescence of ANS in the presence of our samples. ANS is a fluorescent dye that
binds to hydrophobic regions on the surface of proteins; this results in an enhanced quantum yield
and in a blue shift of the wavelength of maximum emission (λmax) (Semisotnov et al., 1991;
Cardamone and Puri, 1992). The fluorescence spectra of ANS with HypF-N oligomers alone, αBc,
Clu or M-TTR alone and HypF-N oligomers in the presence of αBc, Clu or M-TTR were acquired
and compared to that of free ANS (Fig. 6). The analysis was performed using HypF-N and
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chaperone concentrations of 48 µM and 9.6 µM, respectively (Fig. 6A-C) or 4 µM and 1 µM,
respectively (Fig. 6D-F). This allowed to observe ANS binding under conditions in which
chaperones do (Mannini et al., 2012) or do not promote appreciable clustering of HypF-N
oligomers in the first and second cases, respectively.
The binding of ANS to hydrophobic regions exposed on the HypF-N oligomers surface at high
concentration (48 µM) results in enhanced quantum yield and in a blue shift of the wavelength of
peak emission from 510-530 nm to 470-490 nm. Similar behaviour was observed when 9.6 µM αBc
and Clu were analysed separately indicating that these chaperones also have hydrophobic regions
exposed on their surface. By contrast, such spectral changes were not observed in the samples
containing M-TTR alone, suggesting that this protein, as expected for a fully folded protein, does
not present clusters of exposed hydrophobic residues on its surface (Jiang et al., 2001).
For the sample containing both 48 µM oligomers and 9.6 µM chaperone, under conditions in
which the chaperone promotes clustering of HypF-N oligomers, the fluorescence spectrum of ANS
corresponds to that obtained from a linear combination (sum) of the ANS fluorescence spectra
obtained with oligomers alone and chaperone alone (Fig. 6A-C). This indicates that the oligomer
surface hydrophobicity does not change after the binding of HypF-N oligomers to αBc, Clu or MTTR under these conditions. By contrast, for the sample containing 4 µM oligomers and 1 µM
chaperone, under conditions in which the chaperone does not promote a significant clustering of
HypF-N oligomers, the fluorescence spectrum of ANS is lower in intensity than that obtained from
a linear combination (sum) of the ANS fluorescence spectra obtained with oligomers alone and
chaperone alone at the same concentrations (Fig. 6D-F). This indicates that the oligomer surface
hydrophobicity is weakly, yet significantly, shielded after the binding to αBc, Clu or M-TTR under
these conditions.
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Figure 6: ANS analysis of HypF-N oligomers. ANS fluorescence spectra in the absence of added proteins
(purple), in the presence of HypF-N oligomers (blue), chaperone (red) and oligomers and chaperones
incubated together (green). The reconstructed spectrum (black) is given by the sum of the spectra of HypF-N
oligomers (blue) and chaperone incubated separately (red). The analysis refers to Bc (A,D), Clu (B,E) and
M-TTR (C,F) with HypF-N and chaperone concentrations of 48 M and 9.6 M (A–C) and 4 M and 1 M
(D–F), respectively.

Bc, Clu and M-TTR inhibit HypF-N oligomer toxicity. The toxicity of HypF-N oligomers and
Bc, Clu or M-TTR, preincubated together or separately, were tested using the 3-[4,5dimethylhiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay on the murine neuroblastoma
N2a cells. When the cells were treated with HypF-N oligomers at a concentration of 4 μM without
chaperones, cell viability was found to be 45.5±1.3% with respect to the untreated cells, taken as
100% (Fig. 7A-C). In the presence of HypF-N oligomers preincubated with low concentrations of
Bc, Clu or M-TTR, cell viability was greater, reaching about 80-85% of the untreated cells, at
chaperone concentrations of 0.25 or 0.5 μM (Fig. 7A-C). In similar experiments, cell viability
decreased at higher chaperone concentrations, down to values of 50-58% at concentrations of 16
μM chaperone. It is important to note, however, that for all chaperone concentrations tested, when
HypF-N oligomers were preincubated with chaperone and then added to cells, the level of the
15

toxicity measured was only slightly higher than that for the corresponding concentration of
chaperone alone (Fig. 7A-C). For example, the measured percent viable cells following incubation
with 4 µM HypF-N oligomers preincubated with 16 µM Bc, Clu and M-TTR were 50.7±3.2%,
52.6±2.3%, 57.7±4.0%, respectively, whereas the corresponding values for cells incubated with
only 16 µM Bc, Clu and M-TTR were 64.8±1.2%, 57.7±3.6%, 61.8±2.3%, respectively. These
data indicate that the toxicity of the HypF-N oligomers is significantly inhibited by the chaperones
and that the residual toxicity largely arises from the chaperone itself, probably from the fraction of
chaperone in an aggregated form.
To test this possibility, we measured the toxicity of an identical sample of 16 µM Clu that had
not undergone lyophilisation and resuspension. No detectable toxicity was observed in this case,
similarly to a protein sample containing 16 µM BSA, used as a negative control, and unlike a
sample containing toxic NaN3, used here as a positive control (Fig. 7D). Overall, the results suggest
that Bc, Clu and M-TTR inhibit HypF-N oligomer toxicity over the range of concentrations used
here. The high levels of toxicity observed when the cells are coincidentally exposed to HypF-N
oligomers and high concentrations of αBc, Clu or M-TTR likely results from a small fraction of
chaperone in an aggregated state, formed after the non-physiological procedure of
lyophilisation/reconstitution.
An early event arising from the cytotoxicity of protein oligomers is a rapid influx of Ca2+ ions
from the cell culture medium into the cytosol, attributable to the interaction of the oligomers with
the cell membrane (Bucciantini et al., 2004; Demuro et al., 2005; Demuro et al., 2011; Zampagni et
al., 2011). We tested the effects on N2a cell Ca2+ dyshomeostasis of HypF-N oligomers alone, αBc,
Clu or M-TTR alone, and HypF-N oligomers incubated with each of these three proteins (Fig. 8).
The intracellular Ca2+-derived fluorescence of cells treated with HypF-N oligomers alone was
remarkably high, unlike untreated cells that presented a very weak intracellular fluorescence. The
Ca2+-derived fluorescence of cells treated with HypF-N oligomers in the presence of αBc, Clu or
M-TTR at 1 μM was significantly less evident than that derived from cells treated with HypF-N
oligomers alone and more similar to the fluorescence of untreated cells. A similar level of
fluorescence was seen when cells were treated with 1 µM Bc, Clu or M-TTR alone. The
fluorescence of cells treated with HypF-N oligomers in the presence of 16 µM αBc, Clu or M-TTR
was high, but similar to that of cells treated with either of the chaperones at the same concentration.
These results confirm those obtained with the MTT assay and together indicate that the toxicity of
HypF-N oligomers is inhibited at all concentrations of αBc, Clu or M-TTR investigated here.
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Figure 7: Cell viability assay following addition of HypF-N oligomers. (A–C) MTT reduction assay on
N2a cells after treatment with HypF-N oligomers and Bc (A), Clu (B) and M-TTR (C). The HypF-N
oligomers (4 M monomer) and each chaperone at the indicated concentration were incubated for 1 h at
37C with shaking together or separately and then added to the cells. Each bar in the histogram represents
the mean % of MTT reduction the standard error of the mean (SEM) of one experiment (n  4). The single,
double and triple asterisks indicate significant differences (p 0.05, p 0.01, p 0.001, respectively) between
the indicated measurements. (D) MTS assay on N2a cells after treatment with freshly purified Clu, BSA and
NaN3 (AZ). Clu and BSA were incubated for 1 h at 37C with shaking and then added to the cells. Each bar
in the histogram represents the mean % of MTS reduction the standard error of the mean (SEM) of one
experiment (n  8). The triple asterisks indicate significant differences (p 0.001) between AZ and the other
mesaurements.
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Figure 8: Analysis of calcium influx following addition of HypF-N oligomers. (A–C) Representative
confocal scanning microscope images showing intracellular Ca2levels in N2a cells after treatment with
HypF-N oligomers (4 M monomer) incubated in the absence or in the presence of Bc (A), Clu (B) and MTTR (C) at the concentration of 1 or 16 M. Images of the cells treated with chaperones incubated separately
at the concentration of 1 and 16 M were also acquired. The green fluorescence arises from the intracellular
Fluo3 probe bound to Ca2. (D) Quantitation of intracellular Ca2-derived fluorescence reported in panels
(A)–(C). Each bar reports the mean and SEM (n  4). The triple asterisks indicate significant differences
(p0.001) between the indicated measurements.
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Discussion
Effects of different concentrations of chaperones. Recently, it has been demonstrated that, even
when present at very low concentrations, molecular chaperones may inhibit the cytotoxicity of
preformed misfolded oligomers formed by A, IAPP and HypF-N and fibrils formed by
apolipoprotein C-II, by binding to them and converting them into larger aggregates (Ojha et al.,
2011; Mannini et al., 2012, Binger et al., 2013). Interestingly, this chaperone-induced effect has
been found to occur in the absence of any major structural reorganisation within the individual
oligomers, which appear to maintain their overall structure and just assemble into larger species.
This effect has also been observed in the presence of tetrameric TTR and, more so, with a variant
engineered to be stable as a monomer, M-TTR (Cascella et al., 2013a). Here we found that the size
of HypF-N aggregates increases with increasing concentrations of αBc, Clu or M-TTR, as
demonstrated by SLS and AFM. The analysis of the protein composition of the aggregates formed
in the presence of a molar excess of Bc, Clu or M-TTR through SDS-PAGE revealed that the
chaperones bind to the oligomers to only a limited extent. Indeed, most of the chaperone remains in
the supernatant, suggesting that these large aggregates arise from the clustering of preexisting
HypF-N oligomers, induced by a small fraction of chaperone molecules, rather than the recruitment
of all available chaperone molecules to the HypF-N aggregates.
At 4 µM concentration (monomer equivalent) of HypF-N oligomers we have observed inhibition
of toxicity over the whole range of chaperone concentrations used in our experiments (0-16 µM), as
demonstrated by the MTT reduction assay and Ca2+ influx measurements on N2a cells. The SLS
and AFM analyses showed that in the presence of the lowest chaperone:HypF-N molar ratio tested
here the oligomers maintain a size similar to that observed in their absence but have a significant
shielding of their hydrophobic surface, whereas in the presence of the highest molar ratio, the
oligomers cluster together reaching a size much higher than that of free oligomers in the absence of
a significant hydrophobic shielding. These results indicate that chaperones can inhibit the
deleterious biological effects of HypF-N oligomers by binding to their surface without affecting
their size, as well as by binding to them and inducing further growth of the aggregated species (Fig.
9). In the first case, the chaperones can bind to the hydrophobic groups exposed on the oligomer
surface, thus shielding them and preventing them from aberrant interactions with the cells. In the
second case, the chaperones can cause a reduction of the surface-volume ratio of the aggregates,
decrease the effective concentrations of aggregated particles and decrease their diffusional mobility,
as previously suggested (Mannini et al., 2012).
The protective effect mediated by chaperones against misfolded protein oligomers, and observed
here in both the presence and absence of their further assembly, allows apparent differences in the
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proposed mechanisms of action of chaperones to be reconciled. Indeed, the concomitant inhibition
of oligomer toxicity and increased oligomer size induced by chaperones, via recruitment of more
misfolded protein oligomers into the aggregates, has been interpreted to mean that chaperoneinduced clustering of oligomers is a strategy used by chaperones to inhibit oligomer toxicity (Ojha
et al., 2011; Mannini et al., 2012, Binger et al., 2013; Cascella et al., 2013a). By contrast, using
single-molecule fluorescence techniques, it has been shown that clusterin and Bc are able to bind
preformed oligomers of A and sequester them from dissociation or further growth into fibrils,
revealing another possible mechanism of action of molecular chaperones which is binding in the
absence of aggregate clustering (Narayan et al., 2011; Narayan et al., 2012). In the case of Clu, the
formation of complexes with misfolded proteins is thought to be relevant in the in vivo clearance of
these aberrant species via membrane-associated receptors, such as the LRP-2 receptor (Hammand et
al., 1997; Cole and Ard, 2000; Bartl et al., 2001).

Figure 9: A cartoon representing the effect of molecular chaperones at low and high concentration,
respectively.

Comparisons with previous studies. Previous reports have shown the effects of molecular
chaperones at sub-stoichiometric concentrations (Mannini et al., 2012; Cascella et al., 2013a).
Although in previous studies an increase in the size of HypF-N aggregates was evident even at very
low concentrations of chaperones (Mannini et al., 2012; Cascella et al., 2013a), the results presented
here show that very large increases in aggregate size becomes significant only in the presence of
higher chaperone:HypF-N molar ratios. This difference is probably due to the use of different
protein concentrations: in the previous studies HypF-N oligomers and chaperones were tested
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typically at concentrations of 12 µM (equivalent monomer concentration) and 1.2-4.8 µM,
respectively, and we observed significant clustering of the HypF-N aggregates. By contrast, the
HypF-N oligomers were used here at concentrations of 4 µM (equivalent monomer concentration)
and a significant increase of HypF-N oligomer size was observed at chaperone concentrations of 4.0
µM or higher. The lower concentration of HypF-N used here is theoretically expected to shift the
equilibrium for the conversion of oligomers and chaperones to chaperone-oligomer complexes (and
of the large assemblies of HypF-N) towards the “reagents”, i.e. increasing the population of the
small oligomeric species of HypF-N and free chaperones, which is indeed experimentally observed.
Consequently, higher concentrations of chaperones were required in this work to determine a
significant increase of HypF-N aggregate size.
Another significant difference between previous and present findings involves the extent of
inhibition of HypF-N oligomer toxicity: previous reports showed a complete or nearly complete
recovery of cell viability following the preincubation of HypF-N oligomers with chaperones
(Mannini et al., 2012; Cascella et al., 2013a), whereas the present experiments indicate levels of cell
viability that were never higher than 85%, even at low concentrations of chaperone. This lower
protective effect may be due to the higher sensitivity of N2a cells used here to measure oligomer
toxicity compared to the SH-SY5Y cells used previously, but may also arise from the lower levels
of chaperone-induced oligomer clustering reached under our conditions of sub-stoichiometic
concentrations of chaperones compared to previous studies (see above), which may render the
chaperones less effective in their protective action.
Conclusions. The protective action of an intracellular chaperone, here Bc, an extracellular
chaperone, here Clu, and the extracellular protein with chaperone-like behaviour M-TTR, has been
evaluated against preformed HypF-N oligomers at different chaperone concentrations. The results
show that the size of the HypF-N oligomers increases with chaperone concentration in all three
cases and that the aggregates can reach a substantially greater size relative to free HypF-N
oligomers with an associated reduction in aggregate toxicity. This protective effect has been
observed at all chaperone concentrations tested, emphasising the efficiency and versatility of these
protein molecules, which act to reduce toxicity both by binding to the oligomers without affecting
their size and shield their hydrophobic surfaces and also by causing them to further assemble into
larger species, with consequent reduction of their surface-volume ratio, effective concentrations of
aggregated particles and diffusional mobility.
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Materials and Methods

Formation of HypF-N toxic oligomers
HypF-N was expressed in E. coli cells and purified using an affinity chromatography column
packed with the HIS-Select Nickel Affinity Gel, as previously described (Campioni et al., 2008).
The purified native protein was stored at -80 °C in 20 mM TRIS, 2 mM DTT, pH 8.0 and used as a
control (native HypF-N). Toxic oligomers of HypF-N were formed by incubating the native protein
at a concentration of 48 M for 4 h at 25 °C in 50 mM acetate buffer, 12 % (v/v) trifluoroethanol
(TFE), 2 mM DTT, pH 5.5. The oligomers were collected by centrifugation at 16,100 x g for 10
min, dried under N2, and resuspended in either 20 mM potassium phosphate, pH 7.0 for
biophysical/biochemical analysis, or in cell culture medium for cell biology tests. Unless stated
otherwise, in all the experiments described below the oligomers were diluted into the same buffer or
medium to a final protein concentration of 4 M (corresponding monomer concentration),
incubated for 1 h at 37 °C with shaking in the presence of increasing concentrations of chaperones
(ranging from 0 to 16 M) and then subjected to biophysical/biochemical analysis or cell biology
assays.
Preparation of chaperones
Human Bc and M-TTR were purified from E. coli expression systems according to previously
published protocols (Horwitz et al., 1998; Jiang et al., 2001). Human Clu was purified from plasma
as previously reported (Wilson and Esterbrook-Smith, 1992). Lyophilized chaperones were
dissolved in water and dialysed against 20 mM potassium phosphate, pH 7.0, 4 °C using a dialysis
membrane with a molecular mass cut-off of 3500 Da (Spectrum Laboratories, Los Angeles, CA,
USA). Most studies were conducted using liophilised and resuspended chaperones due to the
necessity of shipping the samples between collaborating laboratories.
Light scattering measurements
HypF-N oligomers were first diluted in 20 mM potassium phosphate, pH 7.0, to final concentrations
ranging from 0 to 14 M (corresponding monomer concentration) and then incubated without
chaperones for 1 h at 37 °C while shaking. In another set of experiments, HypF-N oligomers at a
corresponding monomer concentration of 4 M were incubated for 1 h at 37 °C with shaking in 20
mM potassium phosphate, pH 7.0 in the presence of 0 to 16 µM Bc, Clu or M-TTR as described
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above. As a control, Bc, Clu and M-TTR alone at a concentration of 16 M were also prepared
under the same conditions. Before adding HypF-N oligomers and/or chaperones, all buffer solutions
were filtered using filters with a cut-off of 0.02 m. Light scattering measurements were performed
using a Zetasizer Nano S or APS (Malvern, Worcestershire, UK) thermostated with a Peltier
temperature controller and using a low volume 3.0 X 3.0 mm cell or 96-well plate. All the
measurements were acquired with fixed parameters (e.g. for the measurements performed on the
Nano S the cell position 4.20 mm, attenuator index 10) at 37 °C.
Tapping mode atomic force microscopy (TM-AFM)
HypF-N oligomers were incubated in the presence of each chaperone as described above. Samples
containing HypF-N oligomers incubated in isolation and in combination of increasing
concentrations of each chaperone were then diluted 100-fold; 10 l aliquots of the diluted samples
were deposited on freshly cleaved mica and dried under mild vacuum. Tapping mode AFM images
were acquired in air using a Multimode SPM, equipped with “E” scanning head (maximum scan
size 10 m) and driven by a Nanoscope V controller, and a Dimension 3100 SPM, equipped with a
‘G’ scanning head (maximum scan size 100 m) and driven by a Nanoscope IIIa controller (Digital
Instruments, Bruker AXS GmbH, Karlsruhe, Germany). Single beam uncoated silicon cantilevers
(type OMCL-AC160TS, Olympus, Tokyo, Japan) were used. The drive frequency was 290-340
kHz and the scan rate was 0.3-0.8 Hz. Aggregate sizes were estimated from heights and widths in
cross section of the topographic AFM images. For aggregates obtained in the presence of
chaperones, to take into account possible asymmetries in the aggregate shape, we considered both
the maximum and minimum widths and the corresponding heights evaluated along the same image
sections.
SDS-PAGE
Oligomers of HypF-N (4 M monomer equivalent concentration) were incubated with 16 M Bc,
Clu or M-TTR as described above. In control experiments oligomers alone and each chaperone
alone were also incubated under the same conditions. Samples were then centrifuged for 10 min at
16,100 x g and the pellet (P) and supernatant (SN) fractions were subjected to sodium
dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis using 15% (w/v)
polyacrylamide gels. Proteins were visualized by Coomassie Blue staining. In other experiments,
samples containing native HypF-N and HypF-N oligomers were centrifuged for 10 min at 16,100 x
g and the P and SN fractions were analysed by SDS-PAGE.
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ANS fluorescence
HypF-N oligomers (48 M or 4 µM monomer concentration) were incubated with 9.6 µM or 1 µM
Bc, Clu or M-TTR, for 1 h at 37 °C while shaking. Oligomers and each chaperone were also
incubated separately under the same conditions. Aliquots of ANS dissolved in 20 mM potassium
phosphate, pH 7.0 were added to the oligomers in order to obtain a final 3:1 molar excess of dye.
Samples with the same final ANS concentration and without HypF-N/chaperones were also
prepared as controls. Fluorescence spectra were acquired using a LS 55 spectrofluorometer (PerkinElmer, Waltham, MA, USA) equipped with a thermostated cell holder attached to Thermo Haake
C25P water bath (Karlsruhe, Germany) at 37 °C and using a 10 x 2 mm quartz cell. The excitation
wavelength was 380 nm.
Cell cultures
Murine Neuro2a (N2a) neuroblastoma cells (A.T.C.C., Manassas, VA, USA) were cultured in
Minimum Essential Medium Eagle (MEM) supplemented with 10% (v/v) Fetal Bovine Serum
(FBS), 1 mM glutamine and antibiotics. Cell cultures were maintained in a 5% CO 2 humidified
atmosphere at 37 °C and grown until 80% confluence for a maximum of 20 passages.
MTT and MTS assays
Cells were treated for 24 h with HypF-N oligomers (4 µM monomer) and chaperones (0-16 µM)
pre-incubated in combination or in isolation for 1 h at 37 °C with shaking in cell culture medium.
The MTT reduction assay was performed on N2A cell cultures as previously described (Campioni
et al., 2010). In another experiment, N2a cells were seeded into the wells of a sterile 96-well plate
to approximately 30% confluence; the growth medium was 90 l/well of 10% (v/v) FCS in
DMEM:F12 containing penicillin/streptomycin. The following day, solutions of freshly purified
Clu and BSA in PBS were gently incubated at 37 °C for 1 h on an orbital shaker, and then added
into quadruplicate wells to give a final concentration of ca. 1 mg/ml (i.e. 16 M). The control wells
received either no additions or 0.1% NaN3. The cultures were subsequently incubated overnight at
37 °C and 5% (v/v) CO2, before performing a CellTiter 96 Aqueous One Solution Cell Proliferation
(MTS) assay according to the manufacturer's instructions (Promega, Fitchburg, WI, USA).
Measurement of intracellular Ca2+ levels
Oligomers of HypF-N (4 µM monomer) were incubated for 1 h at 37 °C with shaking in cell culture
medium with or without 1 μM or 16 μM of αBc, Clu, or M-TTR and then added to N2a cells seeded
on glass coverslips for 60 min at 37 °C. Cells were then loaded for 30 min with 4.4 µM fluo3-AM
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(Molecular Probes, Eugene, OR, USA) with 0.01% (w/v) pluronic acid F-127 (Sigma-Aldrich, St.
Louis, MO, USA) in culture medium at 37 °C. The cells were then washed with PBS and fixed for
10 min at room temperature with 2% (v/v) paraformaldehyde (Sigma-Aldrich, St. Louis, MO, USA)
in PBS. Finally, the paraformaldehyde solution was removed and the coverslips were washed with
PBS and water to be mounted on slides for the confocal microscopy analysis. Cell fluorescence was
analyzed by confocal scanning microscopy as previously described (Campioni et al., 2010;
Zampagni et al., 2011).
Statistical analysis
Data was expressed as mean ± standard error of the mean (SEM). Comparisons between group pairs
were performed using the t-student test. A p-value lower than 0.05 was considered statistically
significant.
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